Search

Your search keyword '"Valeria Pechtner"' showing total 13 results

Search Constraints

Start Over You searched for: Author "Valeria Pechtner" Remove constraint Author: "Valeria Pechtner" Topic internal medicine Remove constraint Topic: internal medicine
13 results on '"Valeria Pechtner"'

Search Results

1. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus

2. Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

Catalog

Books, media, physical & digital resources

3. Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?

4. Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3)

5. CA-020: Tolérance, pharmacocinétique (PK), et pharmacodynamique (PD) du dulaglutide hebdomadaire chez des patients âgés atteints de diabète de type 2 (DT2)

6. CA-033: Relation entre la variation du poids et le contrôle glycémique avec dulaglutide en administration hebdomadaire chez des patients diabétiques de type 2

7. O28 Efficacité et sécurité du dulaglutide en administration hebdomadaire et de l’insuline glargine en administration quotidienne à 52 semaines de traitement chez les patients diabétiques de type 2 (DT2) inclus dans l’étude AWARD-2 (Assesment of Weekly Adminis)

8. The Two-Week Fasting Glucose as a Predictor of Response to Once Weekly Dulaglutide 1.5 mg

9. Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)

10. Efficacy of Once Weekly Dulaglutide Compared with Twice-Daily Exenatide in Patients with Type 2 Diabetes: A Post-Hoc Analysis to Determine the Influence of Baseline HbA1c

11. PO35 Analyse post-hoc des données poolées de deux essais de phase III contrôlés contre placebo AWARD-1 et AWARD-5 (Assessment of weekly administration of LY2189265 in Diabetes – 1 and – 5/ Évaluation de l’administration hebdomadaire de LY2189265 dans le diabète

12. 1.5 Efficacy and Safety of Dulaglutide vs. Metformin in Type 2 Diabetes (AWARD-3) (69-OR)

13. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study